ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 12 analysts with an average price target of $90.52. This is a potential upside of $30.62 (51.12%) from yesterday's end of day stock price of $59.9.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 297 price targets and 280 ratings on display. The stock rating distribution of ARWR is 25.58% HOLD and 74.42% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.75% with an average time for these price targets to be met of 382.34 days.

Highest price target for ARWR is $126, Lowest price target is $35, average price target is $90.52.

Most recent stock forecast was given by MICHAEL YEE from UBS on 15-Oct-2026. First documented stock forecast 07-Feb-2014.

Best performing analysts who are covering ARWR - Arrowhead Pharmaceuticals:

Patrick Trucchio Keay Nakae Chad Mabry Luca Issi Joel Beatty Alethia Young Edward Tenthoff

Currently out of the existing stock ratings of ARWR, 11 are a HOLD (25.58%), 32 are a BUY (74.42%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Mar-2014

$109

$49.1 (81.97%)

$9

16 days ago
(15-Oct-2026)

2/3 (66.67%)

$50.5 (86.32%)

1073

Buy Since 16-Sep-2020

$115

$55.1 (91.99%)

$115

16 days ago
(15-Oct-2026)

23/29 (79.31%)

$56.5 (96.58%)

528

Hold Since 05-Jun-2024

$74

$14.1 (23.54%)

$85

1 months 7 days ago
(24-Sep-2026)

6/7 (85.71%)

$7.93 (12.00%)

283

Buy Since 05-Feb-2021

$120

$60.1 (100.33%)

$120

1 months 30 days ago
(01-Sep-2026)

13/35 (37.14%)

$37.26 (45.03%)

423

Buy Since 12-May-2020

$100

$40.1 (66.94%)

$87

2 months ago
(31-Aug-2026)

20/21 (95.24%)

$17.61 (21.37%)

590

Show more analysts

Please expand the browser size to see the chart

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 382 days for the stock forecasts to be reached, with an average price target met ratio of 80.75%.

Which analyst most recently updated their price target on ARWR (Arrowhead Pharmaceuticals)?

Michael Yee

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Michael Yee works at UBS and has 9 price targets and 9 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Edward Tenthoff with the highest potential upside of $66.1

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

David Lebowitz with the lowest potential downside of -$61.89
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?